Prognosis Excellent For Healthcare
Invesco US - Seeking Alpha - Wed Mar 04, 6:45PM CST
Biopharmaceuticals, M&A activity and healthcare reform to drive performance By Derek Taner Over the bull market of the last three years, healthcare has outperformed the other nine sectors comprising the S&P 500 Index. The sector's...
PBE: 58.47 (-0.79), PSCH: 68.93 (+0.03), PJP: 80.41 (+0.33), PTH: 63.31 (-0.61)
Where Do Cures Reside? The Answer Is In Regenerative Medicine
Life Sciences Report - Seeking Alpha - Fri Jan 09, 7:37AM CST
The practice of medicine is being transformed. The journey has been arduous, but revolutionary stem cell, gene and immunocellular therapies are rapidly moving toward pivotal milestones-and investors in the space should strap in for a rewarding joy...
BBP: 32.37 (-0.23), RXL: 149.91 (+1.63), XBI: 233.86 (-4.12), IHE: 178.85 (-0.32), IHF: 134.41 (+0.34), PPH: 71.99 (+0.73), XHE: 95.03 (-0.32), BBC: 35.07 (-0.58), PTH: 63.31 (-0.61), BBH: 138.45 (+0.69), FHLC: 36.29 (-0.04), IHI: 120.98 (+0.18), CURE: 161.18 (+3.49), FXH: 68.50 (+0.07), VHT: 139.38 (+0.70), RYH: 159.00 (+0.69), PBE: 58.47 (-0.79), IYH: 159.39 (+0.86), FBT: 125.71 (-0.27), XHS: 125.51 (+0.62), XPH: 130.00 (-1.39), XLV: 74.90 (+0.33), SBIO: 31.04 (-0.89), PSCH: 68.93 (+0.03), PJP: 80.41 (+0.33), RXD: 12.24 (-0.14)
Kyle Bass's Assault On Pharma Patents
IP Hawk - at Seeking Alpha - Thu Jan 08, 12:25PM CST
BBP: 32.37 (-0.23), RXL: 149.91 (+1.63), XBI: 233.86 (-4.12), IBB: 366.52 (+1.27), IHE: 178.85 (-0.32), IHF: 134.41 (+0.34), BBC: 35.07 (-0.58), PPH: 71.99 (+0.73), XHE: 95.03 (-0.32), PTH: 63.31 (-0.61), BBH: 138.45 (+0.69), FHLC: 36.29 (-0.04), IHI: 120.98 (+0.18), CURE: 161.18 (+3.49), FXH: 68.50 (+0.07), VHT: 139.38 (+0.70), RYH: 159.00 (+0.69), PBE: 58.47 (-0.79), IYH: 159.39 (+0.86), FBT: 125.71 (-0.27), XHS: 125.51 (+0.62), XPH: 130.00 (-1.39), XLV: 74.90 (+0.33), SBIO: 31.04 (-0.89), PSCH: 68.93 (+0.03), PJP: 80.41 (+0.33), RXD: 12.24 (-0.14)
True Fund Costs: Health Care Sector
David Trainer - Seeking Alpha - Tue Oct 21, 8:30AM CDT
This report focuses on providing investors the true costs incurred when investing in Health Care ETFs and mutual funds. A key component of our fund ratings, Total Annual Cost (TAC) accounts for all the costs borne by investors, including...
RXL: 149.91 (+1.63), PJP: 80.41 (+0.33), BIB: 180.98 (+1.30), PTH: 63.31 (-0.61), FXH: 68.50 (+0.07)